These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 2009615)
41. The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function? Dostal DE; Baker KM Circ Res; 1999 Oct; 85(7):643-50. PubMed ID: 10506489 [TBL] [Abstract][Full Text] [Related]
42. Importance of RAA system and the treatment of patients with ACE inhibition after myocardial infarction. Ray SG; McAlpine HM; Morton JJ; Leckie B; Dargie HJ Angiology; 1991 Apr; 42(4):268-72. PubMed ID: 2014917 [TBL] [Abstract][Full Text] [Related]
43. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure. Mori J; Zhang L; Oudit GY; Lopaschuk GD J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814 [TBL] [Abstract][Full Text] [Related]
44. [Structure of the renin-angiotensin system and its significance in the body]. Obdrzálková D; Krizanová O Cesk Fysiol; 1998 Sep; 47(3):104-14. PubMed ID: 9748760 [TBL] [Abstract][Full Text] [Related]
45. [Effect of the cardiac renin-angiotensin system on hypertrophy]. Ertl G; Schorb W; Gaudron P; Hu K Z Kardiol; 1996; 85 Suppl 6():233-40. PubMed ID: 9064970 [TBL] [Abstract][Full Text] [Related]
46. Alteration of intracellular Ca2(+)-handling and receptor regulation in hypertensive cardiac hypertrophy: insights from Ren2-transgenic rats. Zolk O; Flesch M; Nickenig G; Schnabel P; Böhm M Cardiovasc Res; 1998 Jul; 39(1):242-56. PubMed ID: 9764204 [TBL] [Abstract][Full Text] [Related]
47. Dopamine-angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease. Labandeira-Garcia JL; Rodriguez-Pallares J; Dominguez-Meijide A; Valenzuela R; Villar-Cheda B; Rodríguez-Perez AI Mov Disord; 2013 Sep; 28(10):1337-42. PubMed ID: 23925977 [TBL] [Abstract][Full Text] [Related]
48. Cardiac angiotensinogen and its local activation in the isolated perfused beating heart. Lindpaintner K; Jin MW; Niedermaier N; Wilhelm MJ; Ganten D Circ Res; 1990 Sep; 67(3):564-73. PubMed ID: 2204498 [TBL] [Abstract][Full Text] [Related]
49. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system. Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163 [TBL] [Abstract][Full Text] [Related]
50. The renin-angiotensin system and cardiac remodelling after acute myocardial infarction. Ikram H Heart; 1996 Nov; 76(3 Suppl 3):68-72. PubMed ID: 8983667 [No Abstract] [Full Text] [Related]
51. [Immunologic approach of the blockage of the renin angiotensin system in vivo]. Michel JB; Sayah S; Guettier C; Reade R; Gardes J; Galen FX; Carelli C; Corvol P Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():281-90. PubMed ID: 2847674 [TBL] [Abstract][Full Text] [Related]
52. Pharmacodynamic effects of C-domain-specific ACE inhibitors on the renin-angiotensin system in myocardial infarcted rats. Sharp S; Poglitsch M; Zilla P; Davies NH; Sturrock ED J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1149-58. PubMed ID: 25757657 [TBL] [Abstract][Full Text] [Related]
53. Organisation and functional role of the brain angiotensin system. Llorens-Cortes C; Mendelsohn FA J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3 Suppl 1():S39-48. PubMed ID: 12428219 [No Abstract] [Full Text] [Related]
54. Endothelial renin-angiotensin pathway: evidence for intracellular synthesis and secretion of angiotensins. Kifor I; Dzau VJ Circ Res; 1987 Mar; 60(3):422-8. PubMed ID: 3555883 [TBL] [Abstract][Full Text] [Related]
55. Renin-Angiotensin-Aldosterone Signaling Inhibitors-Losartan, Enalapril, and Cardosten-Prevent Infarction-induced Heart Failure Development in Rats. Kiss K; Fekete V; Pálóczi J; Sárközy M; Murlasits Z; Pipis J; Kheyfets IA; Dugina JL; Sergeeva SA; Epstein OI; Csonka C; Csont T; Ferdinandy P; Bencsik P Altern Ther Health Med; 2016; 22(2):10-7. PubMed ID: 27036051 [TBL] [Abstract][Full Text] [Related]
56. The renin-angiotensin system and cardiac hypertrophy. Yamazaki T; Komuro I; Shiojima I; Yazaki Y Heart; 1996 Nov; 76(3 Suppl 3):33-5. PubMed ID: 8977363 [No Abstract] [Full Text] [Related]
57. Brain angiotensinergic activity: the state of our current knowledge. Speth RC; Brown TE; Barnes RD; Wright JW Proc West Pharmacol Soc; 2003; 46():11-5. PubMed ID: 14699876 [No Abstract] [Full Text] [Related]
58. Inhibition of renin-angiotensin system: implications for diabetes control and prevention. Prabhakar SS J Investig Med; 2013 Mar; 61(3):551-7. PubMed ID: 23360847 [TBL] [Abstract][Full Text] [Related]
59. Histamine H3 Receptor Agonist Imetit Attenuated Isoproterenol Induced Renin Angiotensin System and Sympathetic Nervous System Overactivity in Myocardial Infarction of Rats. Hass C; Panda BP; Khanam R; Najmi AK; Akhtar M Drug Res (Stuttg); 2016 Jun; 66(6):324-9. PubMed ID: 27011384 [TBL] [Abstract][Full Text] [Related]
60. How hematopoietic stem cells know and act in cardiac microenvironment for stem cell plasticity? Impact of local renin-angiotensin systems. Oztürk MA; Güven GS; Haznedaroglu IC Med Hypotheses; 2004; 63(5):866-74. PubMed ID: 15488662 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]